Nonalcoholic steatohepatitis (NASH) is liverinflammation caused by a buildup of fat in the liver. Many people have a buildup of fat in the liver, and for most people it causes no symptoms and no problems. But in some people, the fat causes inflammation of the liver. Because of the inflammation, the liver doesn’t work as well as it should.
NASH can get worse and cause scarring of the liver, which leads to cirrhosis. But the disease doesn't always get worse.
NASH is similar to the kind of liver disease that is caused by long-term, heavy drinking. But NASH occurs in people who don't abuse alcohol.
Experts don't know why some people with a buildup of fat in the liver get NASH and some don't. It could be that something in the environment triggers the inflammation in those people. Or maybe it runs in their families.
Things that put people at risk for NASH and for liver damage include:
Most people who have NASH are 40 to 50 years old and have one or more of the problems listed above. But NASH can happen in people who have none of these risk factors.
You may have no symptoms in the early stages of NASH. Most people who have NASH feel fine and don't know that they have it.
As NASH progresses and liver damage gets worse, you may start to have symptoms such as:
It may take many years for NASH to become severe enough to cause symptoms.
No single test can diagnose NASH. Your doctor will ask you about other health problems you’ve had.
To see if fat is building up in your liver and to rule out other diseases, your doctor may do tests such as:
Your doctor may do a liver biopsy to be sure that you have NASH. In a liver biopsy, your doctor takes a sample of tissue from your liver and checks it for signs of NASH.
There is no treatment for NASH. But you may be able to limit damage to your liver by managing conditions that increase your risk for NASH or make it worse. You can:
Also, ask your doctor or pharmacist about all the medicines you are taking. Some may harm your liver.
|
Learning about nonalcoholic steatohepatitis (NASH): |
|
|
Living with NASH: |
| American Liver Foundation (ALF) | |
| 39 Broadway, Suite 2700 | |
| New York, NY 10006 | |
| Phone: | 1-800-GO-LIVER (1-800-465-4837) |
| Fax: | (212) 483-8179 |
| Web Address: | www.liverfoundation.org |
|
The American Liver Foundation (ALF) funds research and informs the public about liver disease. A nationwide network of chapters and support groups exists to help people with liver disease and their families. ALF also sponsors a national organ donor program to increase public awareness of the continuing need for organs. |
|
| National Digestive Diseases Information Clearinghouse | |
| 2 Information Way | |
| Bethesda, MD 20892-3570 | |
| Phone: | 1-800-891-5389 |
| Fax: | (703) 738-4929 |
| TDD: | 1-866-569-1162 toll-free |
| Email: | nddic@info.niddk.nih.gov |
| Web Address: | www.digestive.niddk.nih.gov |
|
This clearinghouse is a service of the U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the U.S. National Institutes of Health. The clearinghouse answers questions; develops, reviews, and sends out publications; and coordinates information resources about digestive diseases. Publications produced by the clearinghouse are reviewed carefully for scientific accuracy, content, and readability. |
|
Citations
- National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases (1998). Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Available online: http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf.
Other Works Consulted
- Ahmed A, et al. (2006). Nonalcoholic fatty liver disease section of Alcoholic and nonalcoholic fatty liver disease. In MM Wolfe et al., eds., Therapy of Digestive Disorders, 2nd ed., pp. 551–564. Philadelphia: Saunders Elsevier.
- American Gastroenterological Association (2002, reapproved 2008). AGA technical review on nonalcoholic fatty liver disease. Gastroenterology, 123(5): 1705–1725.
- Collantes R, et al. (2004). Nonalcoholic fatty liver disease and the epidemic of obesity. Cleveland Clinic Journal of Medicine, 71(8): 657–664.
- National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases (1998). Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Available online: http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf.
- St. George A, et al. (2009). Independent effects of physical activity in patients with nonalcoholic fatty liver disease. Hepatology, 50(1): 68–76.
| By | Healthwise Staff |
|---|---|
| Primary Medical Reviewer | Kathleen Romito, MD - Family Medicine |
| Specialist Medical Reviewer | W. Thomas London, MD - Hepatology |
| Last Revised | June 27, 2011 |
Next Section:
Frequently Asked QuestionsPrevious Section:
OverviewNext Section:
Other Places To Get HelpPrevious Section:
Frequently Asked QuestionsNext Section:
Related InformationPrevious Section:
Other Places To Get HelpNext Section:
ReferencesPrevious Section:
Related InformationNext Section:
CreditsPrevious Section:
ReferencesLast Revised: June 27, 2011
Author: Healthwise Staff
Medical Review: Kathleen Romito, MD - Family Medicine & W. Thomas London, MD - Hepatology
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
To learn more visit Healthwise.org
© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
RT @sanfordtimg: #sanfordresearch's Dr. Amy Elliott is filling @keloland in on the CRCAIH Annual Summit http://t.co/brWO1zbKUd